Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.
Tag: AstraZeneca PLC
AstraZeneca Releases Fuller Data Backing Its Vaccine
The company said its shot was 76 percent effective at preventing Covid-19, a hair lower than the number it announced earlier this week.
Supply Isn’t the Only Thing Stymying Europe’s Vaccine Rollout
Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.
With a Police Raid and the Threat of Export Curbs on Vaccines, the E.U. Plays Tough
The bloc is tightening export rules in a bid to speed up its disappointing Covid inoculation campaign and stem political criticism.
Cache of 29 Million AstraZeneca Doses in Italy Raises E.U. Suspicions
The company has been at loggerheads with the bloc over vaccine supply shortages and faces stringent export restrictions.
E.U. Will Curb Covid Vaccine Exports for 6 Weeks
The European Union presented new emergency rules that will most likely severely cut exports to Britain and other countries to ease supply shortages at home.
AstraZeneca’s Latest Stumble Again Clouds European Vaccinations
The company defended its claims of 79 percent efficacy for its coronavirus shot and said it would release more up-to-date trial results within 48 hours.
U.S. Health Officials Question AstraZeneca Vaccine Trial Results
According to federal officials, an independent panel of medical experts said the promising results announced by the company on Monday may have relied on “outdated information.”
AstraZeneca’s Covid-19 Vaccine Is Found to Be 79% Effective in U.S. Study
The company is preparing to apply for emergency authorization from the Food and Drug Administration. But the shot may not be needed in the United States.
Rich Countries Signed Away a Chance to Vaccinate the World
Despite warnings, American and European officials gave up leverage that could have guaranteed access for billions of people. That risks prolonging the pandemic.